ArticleClinical and experimental medicine2026
Dietary fatty acids intake and the risk of advanced cardiovascular-kidney-metabolic syndrome: evidence from NHANES 1999-2018.
Article in Clinical and experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular-Kidney-Metabolic syndrome (CKM) is a multisystem disorder involving cardiovascular, renal, and metabolic dysfunction, with advanced stages (3-4) linked to high morbidity and mortality. Dietary fatty acids (FA) play critical roles in lipid metabolism, insulin sensitivity, and inflammation, yet their associations with CKM progression remain unclear. Data were from National Health and Nutrition Examination Survey, with stages 3-4 defined as advanced CKM. Dietary intake of total fat acids (TFA), saturated fatty acids (SFA), monounsaturated fatty acids (MUFA), and polyunsaturated fatty acids (PUFA) was derived from two 24-h recalls and energy-adjusted using the residual method. Multivariable logistic regression and restricted cubic splines assessed associations between FA and advanced CKM. Sensitivity and subgroup analyses were also performed. Among 27,166 participants (median age: 55.0 years; 52.2% male), 6,634 were classified in advanced CKM stages (3-4). Multivariable logistic regression showed that higher intakes of TFA, SFA, and MUFA were significantly associated with advanced CKM. Compared with the lowest quartile, adjusted odds ratios in the highest quartile were 1.35 (95% CI: 1.05-1.40), 1.26 (95% CI: 1.09-1.37), 1.30 (95% CI: 1.10-1.55), and 1.26 (95% CI: 1.09-1.47), respectively. Restricted cubic spline analyses supported positive linear associations across all four fatty acid categories. Findings remained robust in sensitivity analyses excluding cancer patients, and consistent across key subgroups, with no significant interactions observed. Higher dietary intakes of TFA, SFA, MUFA, and PUFA were associated with greater odds of advanced CKM stages. These findings suggest that dietary fat quantity and composition may be important correlates of CKM severity and warrant further investigation in prospective studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.